Sodium selenite suppresses hepatitis B virus transcription and replication in human hepatoma cell lines

Journal of Medical Virology

Volumn 88, Issue 4, 2016, Pages 653-663

  Cheng, Zhikui ^a   Zhi, Xiaoguang ^a   Sun, Ge ^b   Guo, Wei ^c   Huang, Yayun ^b   Sun, Weihua ^b   Tian, Xiaohui ^a   Zhao, Fei ^a   Hu, Kanghong ^a,b  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b HUBEI UNIVERSITY OF TECHNOLOGY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hepatitis B virus; Selenium; Sodium selenite; Suppression

Indexed keywords

ADEFOVIR; ENTECAVIR; GENOMIC DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; SODIUM SELENITE; VIRUS ANTIGEN; VIRUS DNA; VIRUS RNA; ANTIVIRUS AGENT;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HEPATOCELLULAR CARCINOMA CELL LINE; HEPATOMA CELL; HEPG2 CELL LINE; HUH 7 CELL LINE; HUMAN; HUMAN CELL; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TRANSCRIPTION TERMINATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; CELL SURVIVAL; DRUG EFFECTS; DRUG INTERACTION; GENETIC TRANSCRIPTION; GENETICS; LIVER CELL; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

ANTIGENS, VIRAL; ANTIVIRAL AGENTS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CELL LINE, TUMOR; CELL SURVIVAL; DNA, VIRAL; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; RNA, VIRAL; SODIUM SELENITE; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 84955702449     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24366     Document Type: Article

References (45)

1. Bader T, Korba B. 2010. Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro. Antiviral Res 86:241-245.
2. Beck J, Nassal M. 2007. Hepatitis B virus replication. World J gastroenterol 13:48-64.
3. Beck MA. 2007. Selenium and vitamin E status: Impact on viral pathogenicity. J Nutr 137:1338-1340.
4. Beck MA, Levander OA, Handy J. 2003. Selenium deficiency and viral infection. J Nutr 133:1463S-1467S.
5. Bouchard MJ, Schneider RJ. 2004. The enigmatic X gene of hepatitis B virus. J Virol 78:12725-12734.
6. Bouchard MJ, Wang LH, Schneider RJ. 2001. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 294:2376-2378.
7. Buhlmann S, Racek T, Schwarz A, Schaefer S, Putzer BM. 2008. Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: Implications for hepatocarcinogenesis. J Mol Biol 378:20-30.
8. Chu S. 2012. Transcriptional regulation by post-transcriptional modification-role of phosphorylation in Sp1 transcriptional activity. Gene 508:1-8.
9. Doitsh G, Shaul Y. 2003. A long HBV transcript encoding pX is inefficiently exported from the nucleus. Virology 309:339-349.
10. Feng H, Chen P, Zhao F, Nassal M, Hu K. 2013. Evidence for multiple distinct interactions between hepatitis B virus P protein and its cognate RNA encapsidation signal during initiation of reverse transcription. PLoS ONE 8:e72798.
11. Geng X, Huang C, Qin Y, McCombs JE, Yuan Q, Harry BL, Palmer AE, Xia NS, Xue D. 2012. Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction. Proc Natl Acad Sci USA 109:18471-18476.
12. Harthill M. 2011. Review: Micronutrient selenium deficiency influences evolution of some viral infectious diseases. Biol Trace Elem Res 143:1325-1336.
13. Husbeck B, Bhattacharyya RS, Feldman D, Knox SJ. 2006. Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: Two distinct mechanisms of action. Mol Cancer Ther 5:2078-2085.
14. Jones SA, Murakami E, Delaney W, Furman P, Hu J. 2013. Noncompetitive inhibition of hepatitis B virus reverse transcriptase protein priming and DNA synthesis by the nucleoside analog clevudine. Antimicrob Agents Chemother 57:4181-4189.
15. Khan MS, Dilawar S, Ali I, Rauf N. 2012. The possible role of selenium concentration in hepatitis B and C patients. Saudi J Gastroenterol 18:106-110.
16. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN. 2003. Characterization of mammalian selenoproteomes. Science 300:1439-1443.
17. Lee H, Kim HT, Yun Y. 1998. Liver-specific enhancer II is the target for the p53-mediated inhibition of hepatitis B viral gene expression. J Biol Chem 273:19786-19791.
18. Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ, Group REVEALHS. 2013. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles. Hepatology 58:546-554.
19. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. 2009. Control of cccDNA function in hepatitis B virus infection. J Hepatol 51:581-592.
20. Liaw YF, Chu CM. 2009. Hepatitis B virus infection. Lancet 373:582-592.
21. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Corriere M, Cortinovis M. de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, et al. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095-2128.
22. McKenzie RC, Arthur JR, Beckett GJ. 2002. Selenium and the regulation of cell signaling, growth, and survival: Molecular and mechanistic aspects. Antioxid Redox Signal 4:339-351.
23. Metanis N, Hilvert D. 2014. Natural and synthetic selenoproteins. Curr Opin Chem Biol 22C:27-34.
24. Moghadaszadeh B, Beggs AH. 2006. Selenoproteins and their impact on human health through diverse physiological pathways. Physiology 21:307-315.
25. Motavaf M, Safari S, Saffari Jourshari M, Alavian SM. 2013. Hepatitis B virus-induced hepatocellular carcinoma: The role of the virus x protein. Acta Virol 57:389-396.
26. Nassal M. 1992. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 66:4107-4116.
27. Nassal M. 2008. Hepatitis B viruses: Reverse transcription a different way. Virus Res 134:235-249.
28. Ng SA, Lee C. 2011. Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol 46:974-990.
29. Papatheodoridis GV, Manolakopoulos S, Dusheiko G, Archimandritis AJ. 2008. Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. Lancet Infect Dis 8:167-178.
30. Papp LV, Lu J, Holmgren A, Khanna KK. 2007. From selenium to selenoproteins: Synthesis, identity, and their role in human health. Antioxid Redox Signal 9:775-806.
31. Quasdorff M, Protzer U. 2010. Control of hepatitis B virus at the level of transcription. J Viral Hepat 17:527-536.
32. Rayman MP. 2000. The importance of selenium to human health. Lancet 356:233-241.
33. Scaglione SJ, Lok AS. 2012. Effectiveness of hepatitis B treatment in clinical practice. Gastroenterology 142:1360-1368.
34. Schrauzer GN. 2000. Selenomethionine: A review of its nutritional significance, metabolism and toxicity. J Nutr 130:1653-1656.
35. Smith ML, Lancia JK, Mercer TI, Ip C. 2004. Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Res 24:1401-1408.
36. Sunde RA, Raines AM. 2011. Selenium regulation of the selenoprotein and nonselenoprotein transcriptomes in rodents. Adv Nutr 2:138-150.
37. Tang H, Oishi N, Kaneko S, Murakami S. 2006. Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci 97:977-983.
38. Tian X, Zhao F, Cheng Z, Zhou M, Zhi X, Li J, Hu K. 2013. GCN5 acetyltransferase inhibits PGC1alpha-induced hepatitis B virus biosynthesis. Virol Sin 28:216-222.
39. Trepo C, Chan HL, Lok A. 2014. Hepatitis B virus infection. Lancet 384:2053-2063.
40. Uguz AC, Naziroglu M. 2012. Effects of selenium on calcium signaling and apoptosis in rat dorsal root ganglion neurons induced by oxidative stress. Neurochem Res 37:1631-1638.
41. Yu SY, Zhu YJ, Li WG. 1997. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res 56:117-124.
42. Yuen MF, Lai CL. 2001. Treatment of chronic hepatitis B. Lancet Infect Dis 1:232-241.
43. Zeng H. 2009. Selenium as an essential micronutrient: Roles in cell cycle and apoptosis. Molecules 14:1263-1278.
44. Zeng H, Combs GF, Jr. 2008. Selenium as an anticancer nutrient: Roles in cell proliferation and tumor cell invasion. J Nutr Biochem 19:1-7.
45. Zhang W, Ramanathan CS, Nadimpalli RG, Bhat AA, Cox AG, Taylor EW. 1999. Selenium-dependent glutathione peroxidase modules encoded by RNA viruses. Biol Trace Eleme Res 70:97-116.